# US Investment Rules Could Hinder Chinese Biotech Expansion

US proposed investment rules could hinder Chinese biotech expansion. Direct investment and joint ventures face stricter limits. Drug licensing agreements remain unaffected under current rules.

https://www.scmp.com/business/article/3372151/could-new-us-investment-curbs-complicate-chinas-biotech-licensing-surge

Image: https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2026/10/26/38113d6e-319e-49b3-9625-6a1f4b1d7bfd_021a6824.jpg?itok=G4gTZSbu&v=1793001131

#biotech #investment #china #us

---

Canonical URL: https://qwibbit.com/q25249

Created: 2026-10-26T08:25:32.283969+00:00

Last edited: 2026-10-26T08:25:32.283969+00:00

Board: 3

Origin: Syndicated

Original source: https://www.scmp.com/business/article/3372151/could-new-us-investment-curbs-complicate-chinas-biotech-licensing-surge